summary
Introduced
01/13/2020
01/13/2020
In Committee
03/03/2020
03/03/2020
Crossed Over
02/17/2020
02/17/2020
Passed
03/12/2020
03/12/2020
Dead
Vetoed
04/03/2020
04/03/2020
Introduced Session
2019-2020 Regular Session
Bill Summary
AN ACT Relating to establishing a prescription drug affordability1board; amending RCW 43.71C.100; adding new sections to chapter 70.142RCW; and adding a new section to chapter 42.56 RCW.3
AI Summary
This bill establishes a prescription drug affordability board in Washington state. The board will be composed of five members appointed by the governor with expertise in healthcare economics or clinical medicine. The board will identify certain high-cost and high-price increase prescription drugs and biological products, and may choose to conduct a cost review of these products to determine if the manufacturer's pricing substantially exceeds the proposed value of the drug or product. If the board makes such a determination, it can request the manufacturer to enter into negotiations to reduce the cost. The bill also amends existing law to clarify the confidentiality and use of prescription drug cost data collected by the state.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (12)
Karen Keiser (D)*,
Steve Conway (D),
Mona Das (D),
David Frockt (D),
Bob Hasegawa (D),
Sam Hunt (D),
Patty Kuderer (D),
Jamie Pedersen (D),
Emily Randall (D),
Christine Rolfes (D),
Derek Stanford (D),
Claire Wilson (D),
Last Action
Governor vetoed. (on 04/03/2020)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...